IMP1 is a novel posttranscriptional regulator of early erythroid development and embryonic globin output

Katherine A. MacInnes, Ivan Ferrer-Vicens, Minna Hancock, Kongtana Trakarnsanga, Deborah E. Daniels, Marieangela C. Wilson, Jan Frayne

Open source

DOI
10.1182/bloodadvances.2025019406
Published
2026-08-12
Container
Blood Advances
Publisher
American Society of Hematology
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1182/bloodadvances.2025019406,
  title = {IMP1 is a novel posttranscriptional regulator of early erythroid development and embryonic globin output},
  author = {Katherine A. MacInnes and Ivan Ferrer-Vicens and Minna Hancock and Kongtana Trakarnsanga and Deborah E. Daniels and Marieangela C. Wilson and Jan Frayne},
  year = {2026},
  journal = {Blood Advances},
  doi = {10.1182/bloodadvances.2025019406},
  url = {https://doi.org/10.1182/bloodadvances.2025019406}
}

RIS

TY  - JOUR
TI  - IMP1 is a novel posttranscriptional regulator of early erythroid development and embryonic globin output
AU  - Katherine A. MacInnes
AU  - Ivan Ferrer-Vicens
AU  - Minna Hancock
AU  - Kongtana Trakarnsanga
AU  - Deborah E. Daniels
AU  - Marieangela C. Wilson
AU  - Jan Frayne
PY  - 2026
JO  - Blood Advances
DO  - 10.1182/bloodadvances.2025019406
UR  - https://doi.org/10.1182/bloodadvances.2025019406
ER  - 

APA

MacInnes, K. A., Ferrer-Vicens, I., Hancock, M., Trakarnsanga, K., Daniels, D. E., Wilson, M. C., & Frayne, J. (2026). IMP1 is a novel posttranscriptional regulator of early erythroid development and embryonic globin output. Blood Advances. https://doi.org/10.1182/bloodadvances.2025019406

Source records